Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "China Microarray Market Size, Share, Trends & Forecast Analysis - Forecast to 2036" has been added to ResearchAndMarkets.com's offering. The China microarray ...

RNA microarray market grows from USD 1.77 Billion in 2026 to USD 2.52 Billion by 2030, driven by precision medicine, cancer research, AI-driven gene expression analysis and cloud bioinformatics.Dublin ...

SmartPatch is a needle-free, dissolvable microarray patch designed to deliver active compounds directly into the epidermis ...

Genomic analysis is the identification, measurement or comparison of genomic features such as DNA sequence, structural variation, gene expression, or regulatory and functional element annotation at a ...

Guidance shifted upward again, with Q3 raising full-year 2026 revenue to $4.64 billion to $4.66 billion and EPS to $5.40 to $5.45, following Q2’s earlier raise (Q2 guided $4.60 billion to $4.64 ...

In its upcoming report, Illumina (ILMN) is predicted by Wall Street analysts to post quarterly earnings of $1.36 per share, reflecting an increase of 1.5% compared to the same period last year.

A retrospective cohort of 120 amniocenteses at a regional Turkish centre found that chromosomal microarray and exome ...

Micron Biomedical, an Atlanta-based clinical-stage biotechnology company developing needle-free vaccines and therapeutics, has appointed Anand Subramony, Ph.D., as Executive Vice... Read More ...

Illumina () has held its Q3 earnings call. Read on for the main highlights of the call. Illumina’s latest earnings call carried a distinctly upbeat tone, as management detailed ...

Tumor-infiltrating B cells may reveal naturally selected antibodies and new immunotherapy targets, offering a potential path ...

Newswise Latest News: up-to-the-minute news, press releases, and expert sources for journalists in science, health, medicine, ...

Myeloma Paper of the Day, October 31st, Suggested by Robert Orlowski / Angela Dispenzieri, Arwa Bohra, blood neoplasia, ...